Oppenheimer analyst Leland Gershall lowered the price target on Capricor Therapeutics (NASDAQ: CAPR) to $22.00 (from $43.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE